CD52 Expression in Waldenström's Macroglobulinemia: Implications for Alemtuzumab Therapy and Response Assessment
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference21 articles.
1. Waldenstrom's macroglobulinemia: clinical features, complications, and management;Dimopoulos;J Clin Oncol,2000
2. Waldenstrom's macroglobulinaemia: laboratory diagnosis and treatment;Owen;Hematol Oncol,2000
3. Treatment options in Waldenstrom's macroglobulinaemia: the role of the purine analogues;Owen;Exp Opin Pharmacother,2001
4. Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity;Byrd;Ann Oncol,1999
5. CD20-directed antibody-mediated immunotherapy induces and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia;Treon;J Immunother,2001
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monoclonal Antibodies for Waldenström Macroglobulinemia;Hematology/Oncology Clinics of North America;2018-10
2. A safety profile of medications used to treat Waldenström’s macroglobulinemia;Expert Opinion on Drug Safety;2018-06-03
3. Waldenström′s macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection;European Journal of Haematology;2017-10-10
4. Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms;Revista Brasileira de Hematologia e Hemoterapia;2017-07
5. Role of plasma cells in Waldenström macroglobulinaemia;Pathology;2017-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3